Peptide Activator Stabilizes DJ-1 Structure and Enhances Its Activity.

Area of Science:

• Biochemistry
• Neuroscience
• Enzymology

Background:

• DJ-1 enzyme is critical for mitochondrial function and its dysfunction is linked to Parkinson's disease (PD).
• Modulating DJ-1 activity presents a potential therapeutic avenue for PD drug development.
• Understanding DJ-1's regulatory mechanisms is key to developing effective treatments.

Purpose of the Study:

• To investigate the mechanisms by which two specific peptides enhance DJ-1 enzyme activity.
• To explore the potential of these peptides as therapeutic agents for Parkinson's disease.

Main Methods:

• Utilized two peptides (¹⁵EEMETIIPVDVMRRA²⁹ and ⁴⁷SRDVVICPDA⁵⁶) to modulate DJ-1 activity.
• Employed hydrogen/deuterium exchange mass spectrometry (HDXMS) to elucidate the molecular interactions and mechanisms of action.
• Analyzed the impact of peptide binding on DJ-1's dimeric structure and active site accessibility.

Main Results:

• HDXMS revealed distinct mechanisms of action for the two peptides.
• Peptide 1 stabilizes the DJ-1 structure by shielding the dimer interface, enhancing substrate binding.
• Peptide 2 destabilizes the core structure, increasing substrate accessibility and DJ-1 activity.

Conclusions:

• The study provides detailed insights into how peptides modulate DJ-1 activity through distinct structural mechanisms.
• These findings support the development of novel therapeutic strategies targeting DJ-1 for Parkinson's disease treatment.
• Optimizing DJ-1 activity via peptide binding offers a promising approach to advance PD therapies.